Lucid Diagnostics (LUCD) Free Cash Flow (2020 - 2026)
Lucid Diagnostics (LUCD) posted Free Cash Flow of -$12.3 million for Q1 2026, up 2.14% on a QoQ basis from -$12.6 million in Q4 2025, and up 1.93% year-over-year from -$12.1 million in Q1 2025.
Lucid Diagnostics (LUCD) Free Cash Flow (2020 - 2026) Analysis & Trends
Lucid Diagnostics' Free Cash Flow history runs 7 years deep, the most recent figure standing at -$12.3 million for Q1 2026.
- Quarterly Free Cash Flow rose 1.93% year-over-year to -$12.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$46.3 million (down 5.1% YoY) and the FY2025 annual result came in at -$46.7 million, down 5.05% from the prior year.
- Free Cash Flow was -$12.3 million for Q1 2026 at Lucid Diagnostics, up from -$12.6 million in the prior quarter.
- Across five years, Free Cash Flow topped out at -$4.3 million in Q4 2022 and bottomed at -$15.4 million in Q2 2022.
- A 5-year average of -$9.9 million and a median of -$10.2 million in 2024 frame the typical range for Free Cash Flow.
- Peak annual rise in Free Cash Flow reached 60.21% in 2022, while the deepest fall reached 569.15% in 2022.
- Lucid Diagnostics' Free Cash Flow stood at -$4.3 million in 2022, then sank by 134.36% to -$10.0 million in 2023, then grew by 1.08% to -$9.9 million in 2024, then retreated by 27.49% to -$12.6 million in 2025, then climbed by 2.14% to -$12.3 million in 2026.
- Business Quant data shows LUCD's Free Cash Flow at -$12.3 million in Q1 2026, -$12.6 million in Q4 2025, and -$10.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 916.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 415.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 2.09 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 171.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -21.10 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 449.00 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 305.56 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 112.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Lucid Diagnostics | 133.09 Mn | 105.22 Mn | -325,000.00 | -12.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12.32 Mn |
| Mar 31, 2026 | -12.32 Mn |
| Dec 31, 2025 | -12.59 Mn |
| Dec 31, 2025 | -12.59 Mn |
| Sep 30, 2025 | -10.89 Mn |
| Sep 30, 2025 | -10.89 Mn |
| Jun 30, 2025 | -10.55 Mn |
| Jun 30, 2025 | -10.55 Mn |
| Mar 31, 2025 | -12.56 Mn |
| Mar 31, 2025 | -12.56 Mn |
| Dec 31, 2024 | -9.87 Mn |
| Dec 31, 2024 | -9.87 Mn |
| Sep 30, 2024 | -10.18 Mn |
| Sep 30, 2024 | -10.18 Mn |
| Jun 30, 2024 | -11.48 Mn |
| Jun 30, 2024 | -11.48 Mn |
| Mar 31, 2024 | -12.61 Mn |
| Mar 31, 2024 | -12.61 Mn |
| Dec 31, 2023 | -9.98 Mn |
| Dec 31, 2023 | -9.98 Mn |